The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases
DCGI-approved semaglutide syringes for diabetes and obesity expand treatment choices and improve affordability
The approval is expected to support the company’s presence in regulated international markets and further strengthen its position as a reliable pharma manufacturing partner
A first-of-its-kind national platform honouring the people and institutions shaping the next chapter of life sciences in India
The companies say the drug has now demonstrated clinical benefit in three separate Phase 3 trials
The transaction includes an upfront payment of $1.55 billion, along with up to $1.1 billion in regulatory and commercial milestone payments
The facility sets a new benchmark in respiratory diagnostics
The initiative opens pathways for female students to pursue healthcare programs across 20+ top universities and colleges in India
Regulatory clearance strengthens company’s global footprint and expands access to the Australian animal healthcare market
New PARTNER trial sub-study data show that post-operative ctDNA detection using tumour-informed MRD assays can accurately predict distant recurrence risk in triple-negative breast cancer patients
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
